Johan L.
- Country
- Germany
- Department
- Zentrum Innere Medizin
Research Overview
- Everolimus-Based Calcineurin Inhibitor‑Free Immunosuppression Versus Standard CNI Regimen in Liver Transplant Recipients Beyond One Year: A Phase III Randomized Trial
- Comparison of Neoadjuvant Radiochemotherapy Versus Chemotherapy in Locally Advanced Resectable Gastroesophageal Junction Adenocarcinoma Using Fluorouracil, Docetaxel, Oxaliplatin, and Calcium Folinate
- Phase III Trial of Perioperative FLOT with HIPEC Versus FLOT Alone in Resectable Diffuse Gastric and Gastroesophageal Junction Adenocarcinoma
Data & Insights
Has run more than one trial at 14 of 58 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating gastroesophageal junction adenocarcinomas, with particular emphasis on both localized and advanced disease states.
- GEJ Adenocarcinoma Types I-III
- Diffuse Type Gastric Cancer
Their clinical focus includes evaluation of resectable tumors at the gastroesophageal junction.
Therapeutic Approaches
The investigator works with various treatment modalities for upper gastrointestinal cancers, incorporating both systemic and local therapies.
- Neoadjuvant Radiochemotherapy
- Perioperative Chemotherapy
- Surgical Resection Techniques
Their expertise extends to multimodal treatment strategies for gastroesophageal malignancies.
Clinical Outcomes
The investigator focuses on improving survival outcomes in patients with resectable gastroesophageal cancers.
- Progression-Free Survival Assessment
- Disease-Free Survival Evaluation
- Surgical Outcome Analysis
Their work encompasses long-term monitoring of treatment effectiveness in gastrointestinal cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.